Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide

OBJECTIVES: The purpose of this study was to determine the predictive significance of pretreatment pan-immune-inflammation value (PIV) in patients with newly diagnosed glioblastoma multiforme (GBM) who received postsurgical radiation (RT) and concurrent plus adjuvant temozolomide (TMZ). METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Topkan, Erkan, Kucuk, Ahmet, Selek, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722312/
https://www.ncbi.nlm.nih.gov/pubmed/36479136
http://dx.doi.org/10.1155/2022/1346094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722312/
https://www.ncbi.nlm.nih.gov/pubmed/36479136
http://dx.doi.org/10.1155/2022/1346094

Ejemplares similares